Nouveau Life Pharmaceuticals Inc (NOUV)

[longtime-holder]

Agreed. The changes were very important - none of us should underestimate that - however until there's something actually occurring in the way of sales of their products there remains nothing at the present time to account for any increase in valuation.

The name change alone is obviously not enough; that should go without saying, and people should not be expecting a pop just because of this. They are not an established company yet; no one is going to buy in on the strength of their name alone. The changes were foundational, but the house still has a lot of work to be done on it before it will look like a house.

Patience is the key here.